The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy ; volume:23 ; number:1 ; day:17 ; month:3 ; year:2023 ; pages:1-14 ; date:12.2023
BMC neurology ; 23, Heft 1 (17.3.2023), 1-14, 12.2023
- Creator
-
Yarlas, Aaron
Lovley, Andrew
Brown, Duncan
Vera-Llonch, Montserrat
Khella, Sami
Karam, Chafic
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12883-023-03116-7
- URN
-
urn:nbn:de:101:1-2023080521124847323426
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yarlas, Aaron
- Lovley, Andrew
- Brown, Duncan
- Vera-Llonch, Montserrat
- Khella, Sami
- Karam, Chafic
- SpringerLink (Online service)
Other Objects (12)
Becoming familiar with hereditary transthyretin amyloidosis, a treatable neuropathy
Altered gut microbiota in Taiwanese A97S predominant transthyretin amyloidosis with polyneuropathy
Real-world tafamidis experience in hereditary transthyretin amyloidosis with peripheral neuropathy in Brazil
A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis
Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform
Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort
Tafamidis for autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis: a review
Heterogenous electrophysiological features in early stage of hereditary transthyretin amyloidosis neuropathy
Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study
Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
Hereditary transthyretin amyloidosis overview
Prevalence of hereditary transthyretin amyloid polyneuropathy in idiopathic progressive neuropathy in conurban areas
Becoming familiar with hereditary transthyretin amyloidosis, a treatable neuropathy
Altered gut microbiota in Taiwanese A97S predominant transthyretin amyloidosis with polyneuropathy
Real-world tafamidis experience in hereditary transthyretin amyloidosis with peripheral neuropathy in Brazil
A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis
Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform
Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort
Tafamidis for autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis: a review
Heterogenous electrophysiological features in early stage of hereditary transthyretin amyloidosis neuropathy
Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study
Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
Hereditary transthyretin amyloidosis overview
Prevalence of hereditary transthyretin amyloid polyneuropathy in idiopathic progressive neuropathy in conurban areas
Becoming familiar with hereditary transthyretin amyloidosis, a treatable neuropathy
Altered gut microbiota in Taiwanese A97S predominant transthyretin amyloidosis with polyneuropathy
Real-world tafamidis experience in hereditary transthyretin amyloidosis with peripheral neuropathy in Brazil
A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis
Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform
Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort
Tafamidis for autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis: a review
Heterogenous electrophysiological features in early stage of hereditary transthyretin amyloidosis neuropathy
Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study
Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
Hereditary transthyretin amyloidosis overview